Cardinal Health Inc (CAH) : Zurcher Kantonalbank (zurich Cantonalbank) reduced its stake in Cardinal Health Inc by 0.13% during the most recent quarter end. The investment management company now holds a total of 304,540 shares of Cardinal Health Inc which is valued at $25,776,266 after selling 386 shares in Cardinal Health Inc , the firm said in a disclosure report filed with the SEC on Aug 1, 2016.Cardinal Health Inc makes up approximately 0.33% of Zurcher Kantonalbank (zurich Cantonalbank)’s portfolio.
Other Hedge Funds, Including , Clark Estates Incny boosted its stake in CAH in the latest quarter, The investment management firm added 38,000 additional shares and now holds a total of 80,000 shares of Cardinal Health Inc which is valued at $6,771,200. Cardinal Health Inc makes up approx 1.27% of Clark Estates Incny’s portfolio.Stevens First Principles Investment Advisors boosted its stake in CAH in the latest quarter, The investment management firm added 765 additional shares and now holds a total of 27,520 shares of Cardinal Health Inc which is valued at $2,300,672. Cardinal Health Inc makes up approx 1.67% of Stevens First Principles Investment Advisors’s portfolio.Huntington National Bank reduced its stake in CAH by selling 29,293 shares or 17.61% in the most recent quarter. The Hedge Fund company now holds 137,033 shares of CAH which is valued at $11,420,330. Cardinal Health Inc makes up approx 0.28% of Huntington National Bank’s portfolio.Hollencrest Securities reduced its stake in CAH by selling 82 shares or 2.58% in the most recent quarter. The Hedge Fund company now holds 3,099 shares of CAH which is valued at $249,098. Cardinal Health Inc makes up approx 0.04% of Hollencrest Securities’s portfolio.
Cardinal Health Inc closed down -1.06 points or -1.25% at $83.58 with 17,93,462 shares getting traded on Thursday. Post opening the session at $84.52, the shares hit an intraday low of $83.51 and an intraday high of $84.8 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.
On the company’s financial health, Cardinal Health Inc reported $1.14 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 2, 2016. Analyst had a consensus of $1.13. The company had revenue of $31384.00 million for the quarter, compared to analysts expectations of $31167.11 million. The company’s revenue was up 13.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.00 EPS.
Many Wall Street Analysts have commented on Cardinal Health Inc. Cardinal Health Inc was Resumed by BofA/Merrill to “Neutral” on Jun 7, 2016.
Cardinal Health Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States the Company’s Pharmaceutical segment distributes branded and generic pharmaceutical over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers hospitals and other healthcare providers. In China the Pharmaceutical segment distributes branded generic and specialty pharmaceutical over-the-counter healthcare and consumer products provides logistics marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical surgical and laboratory products and provides services to hospitals ambulatory surgery centers clinical laboratories and other healthcare providers.